Pyrimidine derivatives and processes for the preparation thereof
First Claim
1. Pyrimidine derivative compounds of formulae (I-1) and (I-2) inclusive of pharmaceutically acceptable salts thereof:
- ##STR9## wherein;
R4 and R5, which may be the same or different, are independently hydrogen or a C1 -C3 alkyl group, or jointly form a cyclopentyl or cyclohexyl ring;
A is a group of formula(II);
##STR10## wherein R1 and R2 are, independently of each other, hydrogen or a C1 -C3 alkyl group, and R3 is hydrogen, a C1 -C3 alkyl group or a halogen; and
B is 1-(substituted)-1,2,3,4-tetrahydroisoquinolin-2-yl of formula (III-1) or 7-(substituted)-4,5,6,7-tetrahydrothieno 2,3-c!pyridin-6-yl of formula (III-2) ##STR11## wherein R6 is hydrogen or a C1 -C3 alkyl group.
2 Assignments
0 Petitions
Accused Products
Abstract
The present invention relates to novel pyrimidine derivatives of the formulae (I-1) and (I-2) and pharmaceutically acceptable salts thereof which possess an excellent anti-secretory activity, pharmaceutical compositions containing same as an active ingredient, their novel intermediates, and processes for the preparation thereof: ##STR1## wherein: R4 and R5, which may be the same or different, are independently hydrogen or a C1 -C3 alkyl group, or jointly form a cyclopentyl or cyclohexyl ring;
A is a group of formula(II): ##STR2## wherein R1 and R2 are, independently of each other, hydrogen or a C1 -C3 alkyl group, and R3 is hydrogen, a C1 -C3 alkyl group or a halogen; and
B is 1-(substituted)-1,2,3,4-tetrahydroisoquinolin-2-yl of formula (III-1) or 7-(substituted)-4,5,6,7-tetrahydrothieno 2,3-c!pyridin-6-yl of formula (III-2) ##STR3## wherein R6 is hydrogen or a C1 -C3 alkyl group.
84 Citations
13 Claims
-
1. Pyrimidine derivative compounds of formulae (I-1) and (I-2) inclusive of pharmaceutically acceptable salts thereof:
- ##STR9## wherein;
R4 and R5, which may be the same or different, are independently hydrogen or a C1 -C3 alkyl group, or jointly form a cyclopentyl or cyclohexyl ring;A is a group of formula(II);
##STR10## wherein R1 and R2 are, independently of each other, hydrogen or a C1 -C3 alkyl group, and R3 is hydrogen, a C1 -C3 alkyl group or a halogen; andB is 1-(substituted)-1,2,3,4-tetrahydroisoquinolin-2-yl of formula (III-1) or 7-(substituted)-4,5,6,7-tetrahydrothieno 2,3-c!pyridin-6-yl of formula (III-2) ##STR11## wherein R6 is hydrogen or a C1 -C3 alkyl group. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13)
- ##STR9## wherein;
Specification